KRX-725

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKRX-725
Drug Alias NameKRX-725KRX-341
ClassificationSmall molecules
Mechanisms of ActionEndothelin receptor agonistsAngiogenesis stimulantsProtein kinases modulators
TargetsEndothelin receptorProtein kinases
Therapy Area/IndicationsPeripheral Vascular DiseasesMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKeryx Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKeryx Biopharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A